This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

MRI Interventions Announces Quarterly Product Revenues In Excess Of $1 Million For The First Time For The Fourth Quarter Of 2013

Full Year Product Revenues Exceed Guidance MRI Interventions Sets Date to Report Full Financial Results

MEMPHIS, Tenn., March 10, 2014 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a commercial stage medical device company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart, announced today its fourth quarter and full year product revenues for 2013. MRI Interventions also announced the date on which it will release its full financial results for the quarter and year ended December 31, 2013.

Product Revenues

"We are very pleased to have achieved a milestone during the fourth quarter as we recorded product revenues of $1.1 million, which was the first time our quarterly product revenues exceeded $1 million," said Kimble Jenkins, CEO of MRI Interventions. "The $1.1 million in product revenues for the quarter represents more than 200% growth over the fourth quarter of 2012. Our total product revenues for 2013 of $2.9 million also sets a record, exceeding our previously announced guidance on product revenues of $2.5 million to $2.8 million. We look forward to sharing our full results and providing an update on our progress later this month," said Jenkins.

Quarter Ended December 31, 2013

MRI Interventions recorded product revenues of $1.1 million for the quarter ended December 31, 2013, compared to $339,000 for the same period in 2012, an increase of 226%. ClearPoint disposable product revenues were $562,000 for the quarter ended December 31, 2013, compared with $308,000 for the same period in 2012, representing growth of 82%. Revenues from ClearPoint system reusable component sales were $545,000 in the fourth quarter 2013, compared to $31,000 in the quarter ended December 31, 2012.

Year Ended December 31, 2013

MRI Interventions recorded product revenues of $2.9 million for the year ended December 31, 2013, compared to $1.2 million for the prior year, an increase of 149%. Product revenues included ClearPoint system disposable product sales for the year ended December 31, 2013 of $1.8 million, compared with $1.0 million for the prior year, representing growth of 75%. Revenues from sales of ClearPoint system reusable components were $1.1 million for the year ended December 31, 2013, compared with $150,000 for the prior year, an increase of $982,000.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $92.43 -0.87%
FB $118.64 0.70%
GOOG $706.31 0.70%
TSLA $212.80 0.60%
YHOO $36.87 -0.19%


Chart of I:DJI
DOW 17,659.79 -0.92 -0.01%
S&P 500 2,046.33 -4.30 -0.21%
NASDAQ 4,701.82 -15.2740 -0.32%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs